Age-Related Changes in Bone-Marrow Mesenchymal Stem Cells.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Neuroscience

Background:

• Mesenchymal stromal cells (MSCs) show therapeutic promise for various diseases.
• The impact of donor organism age on MSC therapeutic effectiveness remains unclear.
• Stem cells possess intrinsic mechanisms to resist senescence.

Purpose of the Study:

• To investigate physiological changes in MSCs from aged rats.
• To compare the neuroprotective properties of MSCs from young and old rats in a traumatic brain injury model.
• To determine if donor age affects MSC senescence and function.

Main Methods:

• Evaluation of physiological changes in MSCs from young and old rats.
• Assessment of MSC neuroprotective effects in a rat traumatic brain injury model.
• Analysis of MSC growth rate, PCNA levels, respiratory activity, glucose utilization, autophagy flux, and ultrastructure.

Main Results:

• MSCs promoted remarkable functional recovery in a traumatic brain injury model, with fetal cells showing the highest potency.
• Young MSCs exhibited faster growth and higher glucose utilization compared to old MSCs.
• No significant differences were observed in respiratory activity or autophagy flux between young and old MSCs, but ultrastructural differences were noted.

Conclusions:

• While donor age influences MSC characteristics like growth and metabolism, MSCs from both young and old rats demonstrate neuroprotective capabilities.
• The intrinsic ability of stem cells to resist senescence may contribute to their sustained therapeutic potential across different ages.
• Further research is needed to fully elucidate the role of donor age in MSC-based therapies.